Physician profile
Kristen Nichole Gumpf
NPI 1477934131
$142,377.99
in general payments reported to CMS, 2019-2025
42 companies · $56K in 2025
The $56K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,555 · 2022: $14K · 2023: $23K · 2024: $43K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $70K · Travel and Lodging: $26K · Food and Beverage: $17K · Consulting Fee: $8,756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $70,338.75 |
| Travel and Lodging | $26,383.61 |
| Food and Beverage | $17,044.21 |
| Consulting Fee | $8,756.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $45,545.43 | 2024-2025 | Xiaflex, Aveed |
| Boston Scientific Corporation | $43,169.52 | 2022-2025 | Advance Xp, Ams 700, General - Erectile Dysfunction |
| Endo Pharmaceuticals INC. | $37,303.07 | 2021-2024 | Xiaflex, Aveed |
| Coloplast Corp | $8,027.62 | 2023-2025 | Titan |
| Axonics, INC. | $1,414.29 | 2022-2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $924.29 | 2021-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $531.97 | 2021-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $507.22 | 2023-2025 | Gemtesa, Orgovyx |
| Myovant Sciences INC. | $472.61 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $466.84 | 2021-2025 | Provenge |
| Accord Healthcare, INC. | $442.50 | 2022-2025 | |
| Antares Pharma, INC. | $395.83 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $371.45 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $305.04 | 2021-2025 | Lynparza |
| Tolmar Pharmaceuticals, INC. | $300.48 | 2021-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $280.58 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $252.36 | 2021-2025 | Lynparza, Keytruda, Welireg |
| Urovant Sciences INC | $176.61 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $164.06 | 2021-2025 | Prolaris |
| Tolmar, INC. | $144.92 | 2023-2025 | Jatenzo, Eligard |
| Blue Earth Diagnostics | $125.10 | 2021-2022 | |
| Pfizer INC. | $105.27 | 2021-2025 | |
| Abbvie INC. | $101.37 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $78.93 | 2022-2025 | Pylarify |
| Hollister Incorporated | $78.68 | 2021-2022 | |
| Urogen Pharma, INC. | $75.91 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $65.93 | 2023 | Yonsa |
| Travere Therapeutics, INC. | $65.37 | 2021-2022 | |
| Calyxo, INC. | $63.21 | 2024-2025 | Cvac Aspiration System |
| Halozyme INC | $55.47 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $48.69 | 2022 | |
| Verity Pharmaceuticals INC. | $46.77 | 2022-2025 | Trelstar |
| Palette Life Sciences, INC. | $41.51 | 2022 | |
| Dentsply Ih Ab | $41.18 | 2021-2025 | Lofric |
| Immunitybio, INC. | $38.55 | 2024 | |
| Teleflex LLC | $33.20 | 2021-2025 | Barrigel |
| Vertex Pharmaceuticals Incorporated | $24.54 | 2024 | |
| Alexion Pharmaceuticals, INC. | $20.94 | 2022 | |
| Medtronic, INC. | $19.98 | 2025 | Altaviva |
| Hologic Sales and Service, LLC | $19.57 | 2024 | Aptima |
| Olympus America INC. | $16.03 | 2022 | |
| Acerus Pharmaceuticals Corporation | $15.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Gumpf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.